United States· US:76179-010_41b0fa95-dac0-4df9-a315-c270de6a43c1

QIVIGY

A medicinal product containing human immunoglobulin g, registered in United States by Kedrion S.p.A..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedQIVIGYATC—REGISTER NO.US:76179-010_41b0fa95…PACKS LISTED2CHECKEDJune 3, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
human immunoglobulin g
Manufacturer
Kedrion S.p.A.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 2

  • ndc11
    7617901002
    1 VIAL, GLASS in 1 CARTON (76179-010-02) / 50 mL in 1 VIAL, GLASS (76179-010-01)
  • ndc11
    7617901004
    1 VIAL, GLASS in 1 CARTON (76179-010-04) / 100 mL in 1 VIAL, GLASS (76179-010-03)

Regulatory notes

UNII (FDA substance ID)
66Y330CJHS
HUMAN IMMUNOGLOBULIN G
RxCUI 1426680
DailyMed SPL labels
1 version tracked

Same medicine, other countries

Human immunoglobulin g in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human immunoglobulin g products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Cutaquig, Cuvitru
  • Belgium · Cutaquig, Cuvitru
  • Bulgaria · Имуновенин, Интратект
  • Cyprus · Gamunex, Intratect
  • Czechia · Cutaquig, Cuvitru
  • Germany · Beriglobin, Cutaquig
  • Denmark · Cutaquig, Cuvitru
  • Estonia · Cutaquig, Gammanorm
  • Spain · Cutaquig, Cuvitru
  • Finland · Cutaquig, Cuvitru
  • France · Clairyg, Cutaquig
  • United Kingdom (Northern Ireland) · Cutaquig, Cuvitru
  • Greece · Gaminex, Ig Vena
  • Croatia · Cutaquig, Ig Vena
  • Hungary · Cutaquig, Gammanorm
  • Ireland · Cutaquig, Cuvitru
  • Iceland · Cutaquig, Deqsiga
  • Italy · Cutaquig, Cuvitru
  • Liechtenstein · Deqsiga, Flebogamma Dif
  • Lithuania · Cutaquig, Gammanorm
  • Luxembourg · Cutaquig, Gammagard S/D (Solvent/Detergent)
  • Latvia · Cutaquig, Gammanorm
  • Malta · Cutaquig, Gammanorm
  • Netherlands · Cutaquig, Cuvitru
  • Norway · Cutaquig, Cuvitru
  • Poland · Cutaquig, Cuvitru
  • Portugal · Cutaquig, Gammanorm
  • Romania · Cutaquig, Gammanorm
  • Sweden · Cutaquig, Cuvitru
  • Slovenia · Cutaquig, Gammanorm
  • Slovakia · Cutaquig, Cuvitru

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c49c69d2-787c-43b2-b331-d19e4383b7b3
GET /v1/drugs/c49c69d2-787c-43b2-b331-d19e4383b7b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "66Y330CJHS",
    "rxcui": "1426680",
    "inchikey": null,
    "display_name": "HUMAN IMMUNOGLOBULIN G",
    "substance_type": "structurallyDiverse",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "6f1933e0-240f-48f4-b246-8a30e63a4160": {
      "match": "brand_token",
      "title": "QIVIGY KTHM (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [KEDRION S.P.A.]",
      "spl_version": "4",
      "published_date": "2025-12-02"
    }
  },
  "productid": "76179-010_41b0fa95-dac0-4df9-a315-c270de6a43c1",
  "productndc": "76179-010",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "HUMAN IMMUNOGLOBULIN G",
  "proprietary_name": "QIVIGY",
  "active_ingred_unit": "mg/50mL",
  "application_number": "BLA125822",
  "marketing_category": "BLA",
  "nonproprietary_name": "human immunoglobulin g",
  "start_marketing_date": "20250926",
  "active_numerator_strength": "5"
}

See everything about human immunoglobulin g.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.